ACCUSTEM SCIENCES INC (ACUT) Stock Price, Quote & AI Analysis
Live ACUT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for ACCUSTEM SCIENCES INC.
TradeVae provides AI-driven analysis and real-time market intelligence for ACCUSTEM SCIENCES INC (ACUT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
ACCUSTEM SCIENCES INC's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
ACCUSTEM SCIENCES INC Overview
Company information
Company Overview
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
ACCUSTEM SCIENCES INC Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...